CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 59 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -94.4% | 651 | -89.8% | 0.00% | – |
| Q1 2021 | $18,000 | -91.8% | 6,390 | -93.8% | 0.00% | – |
| Q4 2020 | $220,000 | -72.6% | 102,978 | -20.5% | 0.00% | – |
| Q3 2020 | $802,000 | +266.2% | 129,557 | +281.4% | 0.00% | – |
| Q2 2020 | $219,000 | – | 33,970 | +33533.7% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 101 | -99.4% | 0.00% | – |
| Q3 2019 | $89,000 | +8.5% | 16,490 | +61.4% | 0.00% | – |
| Q2 2019 | $82,000 | – | 10,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eversept Partners, LP | 522,042 | $1,117,170 | 0.13% |
| XTX MARKETS LLC | 26,041 | $56,000 | 0.12% |
| Samsara BioCapital, LLC | 300,000 | $642,000 | 0.06% |
| Ikarian Capital, LLC | 650,000 | $1,392,000 | 0.06% |
| Opaleye Management Inc. | 187,750 | $402,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 108,026 | $231,000 | 0.04% |
| Anson Funds Management LP | 97,601 | $209,000 | 0.04% |
| Virtu Financial LLC | 83,221 | $178,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 47,084 | $101,000 | 0.02% |
| WEXFORD CAPITAL LP | 19,512 | $42,000 | 0.01% |